Literature DB >> 26609468

PAQR3: a novel tumor suppressor gene.

Xin Yu1, Zheng Li2, Matthew Tv Chan3, William Ka Kei Wu4.   

Abstract

PAQR3, also known as RKTG (Raf kinase trapping to Golgi), is a member of the progestin and adipoQ receptor (PAQR) family. The role of PAQR3 as a tumor suppressor has recently been established in different types of human cancer in which PAQR3 exerts its biological function through negative regulation of the oncogenic Raf/MEK/ERK signaling. Multiple studies have found that PAQR3 downregulation frequently occurs in human cancers and is very often associated with tumor progression and shortened patients' survival. Moreover, restoring the expression of PAQR3 could induce apoptosis and inhibit proliferation and invasiveness of cancer cells. Downregulation of PAQR3 by oncogenic microRNAs has also been reported. In this review, we summarized current knowledge concerning the role of PAQR3 in tumor development. To our knowledge, this is the first review on the role of this novel tumor suppressor.

Entities:  

Keywords:  PAQR3; cancer; miRNAs; tumor suppressor

Year:  2015        PMID: 26609468      PMCID: PMC4633890     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  65 in total

1.  PAQR proteins: a novel membrane receptor family defined by an ancient 7-transmembrane pass motif.

Authors:  Y Tom Tang; Tianhua Hu; Matthew Arterburn; Bryan Boyle; Jessica M Bright; Peter C Emtage; Walter D Funk
Journal:  J Mol Evol       Date:  2005-07-21       Impact factor: 2.395

2.  A mathematical model of the regulation of the G1 phase of Rb+/+ and Rb-/- mouse embryonic fibroblasts and an osteosarcoma cell line.

Authors:  M N Obeyesekere; E S Knudsen; J Y Wang; S O Zimmerman
Journal:  Cell Prolif       Date:  1997 Mar-Apr       Impact factor: 6.831

3.  Progesterone effects on lymphocytes may be mediated by membrane progesterone receptors.

Authors:  Kalidou Ndiaye; Daniel H Poole; Sadhat Walusimbi; Matthew J Cannon; Koji Toyokawa; Samar W Maalouf; Jing Dong; Peter Thomas; Joy L Pate
Journal:  J Reprod Immunol       Date:  2012-06-17       Impact factor: 4.054

4.  In vitro combined treatment with cetuximab and trastuzumab inhibits growth of colon cancer cells.

Authors:  T Luca; V Barresi; G Privitera; N Musso; M Caruso; D F Condorelli; S Castorina
Journal:  Cell Prolif       Date:  2014-08-08       Impact factor: 6.831

5.  Rho/ROCK and MEK/ERK activation by transforming growth factor-alpha induces articular cartilage degradation.

Authors:  C Thomas G Appleton; Shirine E Usmani; John S Mort; Frank Beier
Journal:  Lab Invest       Date:  2009-10-12       Impact factor: 5.662

6.  RKTG sequesters B-Raf to the Golgi apparatus and inhibits the proliferation and tumorigenicity of human malignant melanoma cells.

Authors:  Fengjuan Fan; Lin Feng; Jing He; Xiao Wang; Xiaomeng Jiang; Yixuan Zhang; Zhenzhen Wang; Yan Chen
Journal:  Carcinogenesis       Date:  2008-05-29       Impact factor: 4.944

7.  Phylogenetic and preliminary phenotypic analysis of yeast PAQR receptors: potential antifungal targets.

Authors:  Nancy Y Villa; Patricia Moussatche; Stephen G Chamberlin; Anuj Kumar; Thomas J Lyons
Journal:  J Mol Evol       Date:  2011-10-19       Impact factor: 2.395

8.  Single nucleotide polymorphisms of microRNA processing machinery genes and outcome of hepatocellular carcinoma.

Authors:  Shuang Liu; Jie An; Jianhong Lin; Yanli Liu; Lidao Bao; Wen Zhang; Jian-Jun Zhao
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

9.  MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3.

Authors:  Jufeng Zhang; Yanxin Lu; Xupeng Yue; Huiming Li; Xia Luo; Ying Wang; Kepeng Wang; Jun Wan
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.

Authors:  Toshihiko Itesako; Naohiko Seki; Hirofumi Yoshino; Takeshi Chiyomaru; Takeshi Yamasaki; Hideo Hidaka; Tomokazu Yonezawa; Nijiro Nohata; Takashi Kinoshita; Masayuki Nakagawa; Hideki Enokida
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

View more
  10 in total

1.  Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11.

Authors:  Xiaochao Tan; Priyam Banerjee; Hou-Fu Guo; Stephen Ireland; Daniela Pankova; Young-Ho Ahn; Irodotos Michail Nikolaidis; Xin Liu; Yanbin Zhao; Yongming Xue; Alan R Burns; Jonathon Roybal; Don L Gibbons; Tomasz Zal; Chad J Creighton; Daniel Ungar; Yanzhuang Wang; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

2.  Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancer.

Authors:  Ryan Langdon; Rebecca Richmond; Hannah R Elliott; Tom Dudding; Nabila Kazmi; Chris Penfold; Kate Ingarfield; Karen Ho; Andrew Bretherick; Chris Haley; Yanni Zeng; Rosie M Walker; Michael Pawlita; Tim Waterboer; Tom Gaunt; George Davey Smith; Matthew Suderman; Steve Thomas; Andy Ness; Caroline Relton
Journal:  Clin Epigenetics       Date:  2020-06-29       Impact factor: 6.551

3.  PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer.

Authors:  Bin Wu; Rongyu Liu
Journal:  Onco Targets Ther       Date:  2019-05-13       Impact factor: 4.147

Review 4.  Characterization of the Golgi scaffold protein PAQR3, and its role in tumor suppression and metabolic pathway compartmentalization.

Authors:  Lan Lei; Zhe-Nan Ling; Xiang-Liu Chen; Lian-Lian Hong; Zhi-Qiang Ling
Journal:  Cancer Manag Res       Date:  2020-01-16       Impact factor: 3.989

5.  Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism.

Authors:  Haiming Xiao; Xiaohong Sun; Zeyuan Lin; Yan Yang; Meng Zhang; Zhanchi Xu; Peiqing Liu; Zhongqiu Liu; Heqing Huang
Journal:  Acta Pharm Sin B       Date:  2022-01-06       Impact factor: 14.903

6.  PAQR3 controls autophagy by integrating AMPK signaling to enhance ATG14L-associated PI3K activity.

Authors:  Da-Qian Xu; Zheng Wang; Chen-Yao Wang; De-Yi Zhang; Hui-Da Wan; Zi-Long Zhao; Jin Gu; Yong-Xian Zhang; Zhi-Gang Li; Kai-Yang Man; Yi Pan; Zhi-Fei Wang; Zun-Ji Ke; Zhi-Xue Liu; Lu-Jian Liao; Yan Chen
Journal:  EMBO J       Date:  2016-02-01       Impact factor: 11.598

7.  Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma.

Authors:  Ge Bai; Mei Yang; Chao Zheng; Li Zhang; Mayinur Eli
Journal:  Oncol Lett       Date:  2018-02-08       Impact factor: 2.967

8.  Progestin and AdipoQ Receptor 3 Upregulates Fibronectin and Intercellular Adhesion Molecule-1 in Glomerular Mesangial Cells via Activating NF-κB Signaling Pathway Under High Glucose Conditions.

Authors:  Yezi Zou; Zhiquan Chen; Jie Li; Wenyan Gong; Lei Zhang; Futian Xu; Lihao Chen; Peiqing Liu; Heqing Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-07       Impact factor: 5.555

9.  PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability.

Authors:  Ling Jin; Laigen Tong
Journal:  Immun Inflamm Dis       Date:  2021-05-06

10.  Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis.

Authors:  Chunyu Zhang; Pan Liu; Jiaming Huang; Yuandong Liao; Chaoyun Pan; Junxiu Liu; Qiqiao Du; Tianyu Liu; Chunliang Shang; Shiyin Ooi; Run Chen; Meng Xia; Hongye Jiang; Manman Xu; Qiaojian Zou; Yijia Zhou; Hua Huang; Yuwen Pan; Li Yuan; Wei Wang; Shuzhong Yao
Journal:  Cell Death Dis       Date:  2021-09-29       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.